← Eichor
Study identifier: NCT05835518 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS

Condition: Rheumatoid Arthritis · Ankylosing Spondylitis  ·  Sponsor: Yuhan Corporation

PhaseN/A
Planned participants1000
Who can joinAll sexes, 19 Years to 74 Years
Healthy volunteersNo

About this study

This Study is to Assess the Efficacy and Safety of Adalloce in Patients With Rheumatoid Arthritis and Ankylosing Spondylitis, An Observational, Prospective Study

This description comes directly from the study's public registry record.

Talk to the study team

Hee Suh  ·  +82-2-828-0231  ·  hee1110@yuhan.co.kr

Always discuss trial participation with your own doctor first.

Locations (1)

Daegu Catholic University Medical CenterDaegu, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05835518